| Name | Title | Contact Details |
|---|
APLUS INSTITUTE is a North York, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
The Department of Medical Assistance Services plays a critical role in providing health care coverage to low-income children, older adults, individuals with disabilities and pregnant women. There are nearly 400,000 uninsured Virginians eligible for new cost-effective health care options through the same modern and efficient management that is serving the Commonwealth well today
Kaiser Permanente Washington Health Research Institute (KPWHRI) is a non-profit research organization that conducts practical research to improve the health and health care of Kaiser Permanente members and the public.
Established in 1977, HMG's multi-specialty physician practice includes more than 100 physicians and mid-level providers in its provision of 24-hour medical/surgical coverage.
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.